96.19
-0.51
(-0.53%)
At close: January 10 at 3:30:38 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
10,258,000.00
10,526,000.00
10,522,000.00
7,418,000.00
Investing Cash Flow
--
-6,200,000.00
-2,075,000.00
-7,298,000.00
3,619,000.00
Financing Cash Flow
--
-8,052,000.00
-5,821,000.00
-7,056,000.00
-6,485,000.00
End Cash Position
--
8,710,000.00
12,736,000.00
10,098,000.00
13,915,000.00
Income Tax Paid Supplemental Data
--
2,623,000.00
2,452,000.00
1,280,000.00
2,051,000.00
Interest Paid Supplemental Data
--
559,000.00
380,000.00
334,000.00
315,000.00
Capital Expenditure
--
-3,024,000.00
-2,201,000.00
-2,043,000.00
-2,083,000.00
Issuance of Capital Stock
--
195,000.00
188,000.00
186,000.00
203,000.00
Issuance of Debt
--
48,000.00
1,549,000.00
--
2,019,000.00
Repayment of Debt
--
-3,949,000.00
-3,009,000.00
-2,390,000.00
-4,186,000.00
Repurchase of Capital Stock
--
-593,000.00
-497,000.00
-382,000.00
-822,000.00
Free Cash Flow
--
7,234,000.00
8,325,000.00
8,479,000.00
5,335,000.00
12/31/2020 - 10/4/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4AB.F AbbVie Inc.
169.50
-2.47%
NOV.DE Novo Nordisk A/S
84.60
-0.31%
BAYN.DE Bayer Aktiengesellschaft
19.98
+1.13%
OGN Organon & Co.
15.85
-0.94%
GSK GSK plc
33.09
-1.96%
MRK Merck & Co., Inc.
99.25
-0.60%
ABBV AbbVie Inc.
175.17
-1.87%
NVO Novo Nordisk A/S
86.26
+0.72%
PFE Pfizer Inc.
26.72
-0.52%
JNJ Johnson & Johnson
142.06
-0.15%